Health and Healthcare
FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)
Published:
Last Updated:
The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once again why much of the criticism is justified.
The FDA today said that two drugs, each of which has been on the market for many years, react badly when taken together. It is a wonder it took so long to figure this out since each of the drugs is very widely used.
Prilosec, an antacid marketed by AstraZeneca (NYSE:AZN), hurts the effectiveness of Plavix which is the world’s most prescribed blood thinner, Plavix is marketed by Sanofi-Aventis (NYSE:SNY) and Bristol-Myers (NYSE:BMY).
Plavix is essential to the treat heart attack victims, patients with vascular stents, and also helps prevent blood clots in the brain. Any drop in its effectiveness is likely to cause real danger to many patients using Plavix.
The FDA is slow to market with news, once again.
Douglas A. McIntyre
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.